HOUSTON and VANCOUVER, May 14, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment
Growth Capitalist (https://growthcapitalist.com/2018/05/essa-pharma-provides-corporate-update-and-reports-financial-results-for-fiscal-second-quarter-ended-march-31-2018/)
HOUSTON and VANCOUVER, May 14, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment